Apellis Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 1,839 | 0.0% | 73,203 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,659 | 0.0% | 73,298 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 1,522 | 0.0% | 87,929 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,307 | 0.0% | 59,778 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 2,256 | 0.0% | 70,688 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 2,207 | 0.0% | 76,540 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 3,019 | 0.0% | 78,702 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 4,371 | 0.0% | 74,370 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 5,399 | 0.0% | 90,191 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 3,586 | 0.0% | 94,269 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 9,519 | 0.0% | 104,487 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 7,427 | 0.0% | 112,603 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 5,890 | 0.0% | 113,909 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 7,538 | 0.0% | 110,360 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 4,776 | 0.0% | 105,614 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 5,027 | 0.0% | 98,930 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 4,903 | 0.0% | 103,701 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 2,789 | 0.0% | 84,617 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 5,658 | 0.0% | 89,522 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 3,886 | 0.0% | 90,557 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 5,195 | 0.0% | 90,830 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 2,743 | 0.0% | 90,923 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 2,957 | 0.0% | 90,546 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 2,330 | 0.0% | 86,974 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 2,284 | 0.0% | 74,591 | 12/31/2019 |